bioRxiv Science⌕ Search

Biology subjects

Hammar, K. M.

Publications and source records attributed to Hammar, K. M..

2 recordsLinked to original sources

Developmental exposure to domoic acid targets reticulospinal neurons and leads to aberrant myelination in the spinal cord

Harmful algal blooms (HABs) produce neurotoxins that affect human health. Developmental exposure of zebrafish embryos to the HAB toxin domoic acid (DomA) causes myelin defects, loss of reticulospinal neurons, and behavioral deficits. However, it is unclear whether DomA primarily targets myelin sheaths, leading to the loss of reticulospinal neurons, or reticulospinal neurons, causing myelin defects. Here, we show that while exposure to DomA at 2 dpf did not reduce the number of oligodendrocyte precursors prior to myelination, it led to fewer myelinating oligodendrocytes that produced shorter myelin sheaths and aberrantly wrapped neuron cell bodies. DomA-exposed larvae lacked Mauthner neurons prior to the onset of myelination, suggesting that axonal loss is not secondary to myelin defects. The loss of the axonal targets may have led oligodendrocytes to inappropriately myelinate neuronal cell bodies. Consistent with this, GANT61, which reduces oligodendrocyte number, caused a reduction in aberrantly myelinated neuron cell bodies in DomA-exposed fish. Together, these results suggest that DomA initially alters reticulospinal neurons and the loss of axons causes aberrant myelination of nearby cell bodies. The identification of initial targets and perturbed cellular processes provides a mechanistic understanding of how DomA alters neurodevelopment, leading to structural and behavioral phenotypes.

pharmacology and toxicology↗

α-Synuclein-112 impairs synaptic vesicle recycling consistent with its enhanced membrane binding properties

Synucleinopathies are neurological disorders associated with -synuclein overexpression and aggregation. While it is well established that overexpression of wild type -synuclein (-syn-140) leads to cellular toxicity and neurodegeneration, much less is known about other naturally occurring -synuclein splice isoforms. In this study we provide the first detailed examination of the synaptic effects caused by one of these splice isoforms, -synuclein-112 (-syn-112). -Syn-112 is produced by an in-frame excision of exon 5, resulting in deletion of amino acids 103-130 in the C-terminal region. -Syn-112 is upregulated in the substantia nigra, frontal cortex, and cerebellum of parkinsonian brains and is correlated with susceptibility to sporadic Parkinsons disease (PD), dementia with Lewy bodies (DLB) and multiple systems atrophy (MSA). We report here that -syn-112 binds strongly to anionic phospholipids when presented in highly-curved liposomes, similar to -syn-140. However, -syn-112 bound significantly stronger to all phospholipids tested, including the phosphoinositides. -Syn-112 also dimerized and trimerized on isolated synaptic membranes, while -syn-140 remained largely monomeric. When introduced acutely to lamprey synapses, -syn-112 robustly inhibited synaptic vesicle recycling. Interestingly, -syn-112 produced effects on the plasma membrane and clathrin-mediated synaptic vesicle endocytosis that were phenotypically intermediate between those caused by monomeric and dimeric -syn-140. These findings indicate that -syn-112 exhibits enhanced phospholipid binding and oligomerization in vitro and consequently interferes with synaptic vesicle recycling in vivo in ways that are consistent with its biochemical properties. This study provides additional evidence suggesting that impaired vesicle endocytosis is a cellular target of excess -synuclein and advances our understanding of potential mechanisms underlying disease pathogenesis in the synucleinopathies.

neuroscience↗